Archive for June, 2007

Biomedical Treatment Checklist for Autism

ASU Prof. James Adams, Ph.D. is currently conducting research at on the effectiveness of Chelation Therapy and Autism in children. His research group is dedicated to finding the causes of autism, how to prevent autism, and how to best help people with autism. Below are guidlines from his Summary of Biomedical Treatments for Autism to help guide parents through this information and treatment options. For an uncondensed version of this article visit www.awakennutrition.com/asu.html

A condensed version of the DAN! guidelines by James Adams, Ph.D

Follow in this order:

1. Improve quality of diet. Eliminate junk food. Increase intake of vegetables, whole fruit, and protein, while limiting sugar/starch intake.

2. Minimum 3-month trial of total avoidance of casein and gluten.

3. Add digestive enzymes, vitamins, minerals.

4. Test thyroid function and iodine level – consider thyroid hormones and/or iodine.

5. Test for food allergy, using blood.

6. Test gut function: Comprehensive Digestive Stool Analysis and urinary organic acids, using both tests to check for intestinal yeast/bacteria. If necessary, treat with antifungals, probiotics, and possibly antibiotics. Try low sugar/starch diet, and consider Specific Carbohydrate Diet to starve yeast/bacteria.

7. Test for amino acids, and add if necessary.

8. Test plasma sulfate and glutathione; supplement if low.

9. Assess heavy metal toxicity by chelation challenge, and treat if high.

10. Try additional nutrients (Essential fatty acids, DMG/TMG, methyl-B12)

11. Try mega-B6 with Magnesium (8 mg of B6 per pound bodyweight, and 4 mg/pound bodyweight of Magnesium), especially if kryptopyrole test high.

12. Test for viral infections, and treat if necessary.

Behavioral therapy is also strongly recommended, and should be done simultaneously. Applied Behavior Analysis, Relationship Development Intervention, and other methods are available.

Comments

Court Begins Hearings on Vaccine Link to Autism

Interesting article on the court hearings taking place linking Autism to mercury in childhood vaccines… check back for further updates on this important issue:

Tuesday, June 12, 2007


The parents of 12-year-old Michelle Cedillo asked a federal court Monday to find that their child’s autism was caused by common childhood vaccines, a precedent-setting case that could pave the way for thousands of autistic children to receive compensation from a government fund set up to help people injured by the shots.Wearing noise-canceling headphones, Michelle, of Yuma, Ariz., was brought into the courtroom in a wheelchair at the start of the proceedings before the U.S. Court of Federal Claims, She stayed only a short time.

Her parents, Theresa and Michael Cedillo, allege a preservative called thimerosal that had been used in vaccines weakened their daughter’s immune system and prevented her body from clearing the measles virus after she was immunized for the disease at age 15 months.

Today, Michelle suffers from a litany of health problems, including severe autism, inflammatory bowel disease, glaucoma and epilepsy.

“We hope to find out what happened and hopefully get the help she needs,” said Theresa Cedillo, who takes care of her daughter full time at home.

Special Master George Hastings Jr. thanked the family for allowing theirs to be the first of nine test cases that will help guide the resolution of some of the nearly 5,000 similar claims lodged with the government.

“Clearly the story of Michelle’s life is a tragic one,” Hastings said in pledging to listen carefully to the evidence presented during the three-week hearing.

The burden of proof is easier than in a traditional court. Plaintiffs only have to prove that a link between autism and the shots is more likely than not, based on a preponderance of evidence.

Large scientific studies have found no association between autism and vaccines containing thimerosal.

But many partents say their children’s symptoms did not show up until after their children received the vaccines, required by many states for admission to school.

“These are families who followed the rules. These are families who brought children in for vaccines. These are families who immunized their children,” said the Cedillos’ attorney, Thomas Powers.

Powers said that the science regarding a possible vaccine-autism link is in dispute.

Government attorney Vincent Matanoski dismissed much of what the plaintiffs are expected to present as conjecture or speculation.

“You’ll find their hypotheses untested or, when tested, have been found false,” Matanoski said.

Since 1999, more than 4,800 families have filed claims with the government alleging their children developed autism as a result of routine vaccinations. Most contend that a preservative called thimerosal is to blame for the impaired social interaction typical of the disorder.

The court is being asked to decide whether there is a link between autism and childhood vaccines. If it finds one exists, the families could be eligible for compensation under the Vaccine Injury Compensation Fund, a program established by Congress to ensure an adequate supply of vaccines by safeguarding manufacturers from lawsuits. Under the program, people injured by vaccines receive compensation through a special trust fund.

Autism is characterized by impaired social interaction. Those affected often have trouble communicating, and they exhibit unusual or severely limited activities and interests. Classic symptoms of mercury poisoning include anxiety, fatigue and abnormal irritation, as well as cognitive and motor dysfunction.

Monday’s case addresses the theory that the cause of autism is the measles, mumps and rubella vaccine in combination with other vaccines containing thimerosal. The preservative, about 50 percent mercury by weight, is no longer found in routine childhood vaccines but is used in some flu shots.

In July 1999, the U.S. government asked vaccine manufacturers to eliminate or reduce, as expeditiously as possible, the mercury content of their vaccines to avoid any possibility of infants who receive vaccines being exposed to more mercury than is recommended by federal guidelines.

Comments

Chelation Therapy for Heart Disease seminar presented by The Carolina Center for Integrative Medicine

RALEIGH, NC – As part of his continuing Midday Health Series, John C. Pittman, MD, of The Carolina Center for Integrative Medicine (CCIM), will present “Chelation Therapy for Heart Disease” on Thursday, June 14th from 12:15-1:00PM at CCIM’s office at 4505 Fair Meadow Lane, Suite 111 in Raleigh. This free, public health presentation will discuss how chelating drugs have been shown to remove calcium plaque from artery walls, reverse atherosclerosis, and effectively treat heart disease for many individuals.

Heart disease is the number one killer in the United States. Blood vessel diseases, including heart disease, are caused by atherosclerosis or thickening of the arteries, which results from the accumulation of fats, calcium, and other substances in the arterial wall. Modern conventional medical treatment for atherosclerosis of the coronary arteries is focused primarily on invasive procedures to unblock the artery. While this may be life saving to a patient with advanced heart disease, it only addresses one specific section of his blood vessel system. There is another approach to treating circulatory disease called EDTA Chelation Therapy.

Chelation refers to the ability of a chemical compound (EDTA) to bind to a mineral or toxic metal. The binding site of EDTA is negatively charged and therefore likes to grab positively charged substances. EDTA was initially developed to pull calcium out of hard water for use in the textile industry, but was later discovered to have medical benefits in treatment of patients with high blood levels of calcium.

“Over the last thirty years, EDTA chelation research has focused primarily on its effects on the cardiovascular system,” explains Dr. Pittman. “Some of this research has involved beneficial effects seen in patients with chronic lung disease including improved pulmonary function and blood oxygenation. Another study showed that bone density levels in patients with osteoporosis increased to a significant degree following EDTA chelation therapy. Perhaps the most interesting study shows that EDTA chelation will improve kidney function in patients with mild to moderately reduced function as evidenced by improvement in blood chemistry tests.”

Advanced registration is required in case of cancellation. To register, contact Louise Cottrell at (919) 848-1025 extension 3 or via e-mail at register@carolinacenter.com

About the Carolina Center for Integrative Medicine
Since 1994, the Carolina Center for Integrative Medicine has been the Triangle’s leading provider of integrative medical treatments and therapies. Practice founder, Dr. John Pittman, is the only local physician fully certified in chelation therapy for the treatment of heavy metal toxicity and only one of six medical practitioners in the state of North Carolina who is a Diplomate through the American Board of Clinical Metal Toxicology.

The Carolina Center utilizes a combination of the most progressive alternative therapies, along with dietary and lifestyle modifications, to treat a wide variety of chronic illnesses and immune system dysfunctions. Conditions treated include Atherosclerosis & Disorders of Circulation, Chronic Digestive Disturbances, Chronic Infections & Immune Dysfunction, Degenerative Neurological Disorders, Fibromyalgia, Lyme Disease, Natural Hormone Replacement Therapy, Multiple Chemical Sensitivity/Environmental Allergies, and Pediatric Program for Autism. The Carolina Center also provides Chemical Detoxification and support for patients injured through exposure to mold, pesticides, hydraulic fluid, mercury, and sick building syndrome. For more information, call (919) 571-4391 or visit www.carolinacenter.com.

Comments